Le Lézard
Classified in: Covid-19 virus
Subjects: MAT, MRR

Global Cannabis Beverages Strategic Analysis Report 2022-2023 & 2030: Innovation and Safety Measures Drive Growth in Cannabis Beverage Production


DUBLIN, Sept. 13, 2023 /PRNewswire/ -- The "Cannabis Beverages: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

Global Cannabis Beverages Market to Reach $3.9 Billion by 2030

The global market for Cannabis Beverages estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$3.9 Billion by 2030, growing at a CAGR of 17.7% over the analysis period 2022-2030.

The global market for cannabis beverages is experiencing significant growth, with sales expected to increase steadily from 2022 through 2030.  The market encompasses a range of products, including non-alcoholic and alcoholic cannabis beverages, as well as those containing Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

As the market evolves, it presents opportunities and challenges, making it essential to monitor and adapt to changing trends and consumer preferences. This comprehensive assessment provides valuable insights into the cannabis beverages market's past, present, and future dynamics, aiding in strategic decision-making for businesses operating in this evolving industry.

Non-Alcoholic, one of the segments analyzed in the report, is projected to record a 18.2% CAGR and reach US$2.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Alcoholic segment is readjusted to a revised 16.6% CAGR for the next 8-year period.

The Cannabis Beverages market in the U.S. is estimated at US$752 Million in the year 2022. Asia-Pacific is forecast to reach a projected market size of US$258.5 Million by the year 2030 trailing a CAGR of 14.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Europe and Canada, each forecast to grow at 16.9% and 17.5% respectively over the 2022-2030 period.

What's New?

MARKET OVERVIEW

MARKET TRENDS & DRIVERS

FOCUS ON SELECT PLAYERS (Total 79 Featured)

For more information about this report visit https://www.researchandmarkets.com/r/5dl8iq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 07:00
Biglari Capital Corp. today issued the following letter to shareholders of Cracker Barrel Old Country Store, Inc. .  See below for the shareholder letter in its original form. Dear Shareholders of Cracker Barrel Old...

at 07:00
Healgen Scientific LLC, a leading innovator in diagnostic solutions, announced the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for Healgen Rapid Check® COVID-19/Flu A&B Antigen Test for over-the-counter...

at 07:00
Freegold Ventures Limited ("Freegold" or the "Company") is...

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, as a perioperative treatment for patients newly diagnosed with stage III...

at 06:30
Hannan Metals Limited's ("Hannan" or the "Company") is pleased to announce that the company has completed the first stage of a 79 line km Induced Polarization ("IP) geophysical survey at the Previsto Prospect within the...

at 06:30
NanoViricides, Inc. (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, has been invited and will be...



News published on and distributed by: